ARS Pharmaceuticals (SPRY) Intangibles (2023 - 2025)
Historic Intangibles for ARS Pharmaceuticals (SPRY) over the last 3 years, with Q3 2025 value amounting to $14.7 million.
- ARS Pharmaceuticals' Intangibles rose 9638.67% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 9638.67%. This contributed to the annual value of $7.4 million for FY2024, which is 109465.15% up from last year.
- Per ARS Pharmaceuticals' latest filing, its Intangibles stood at $14.7 million for Q3 2025, which was up 9638.67% from $13.0 million recorded in Q2 2025.
- ARS Pharmaceuticals' Intangibles' 5-year high stood at $14.7 million during Q3 2025, with a 5-year trough of $446000.0 in Q2 2024.
- For the 3-year period, ARS Pharmaceuticals' Intangibles averaged around $6.4 million, with its median value being $7.3 million (2024).
- Over the last 5 years, ARS Pharmaceuticals' Intangibles had its largest YoY gain of 280852.02% in 2025, and its largest YoY loss of 9638.67% in 2025.
- Quarter analysis of 3 years shows ARS Pharmaceuticals' Intangibles stood at $617000.0 in 2023, then soared by 1094.65% to $7.4 million in 2024, then soared by 99.82% to $14.7 million in 2025.
- Its Intangibles was $14.7 million in Q3 2025, compared to $13.0 million in Q2 2025 and $7.2 million in Q1 2025.